On ECHEMI
Home > Drugs > Chronic hepatitis B
Chronic hepatitis B
Chronic hepatitis B is a common type of hepatitis B. Hepatitis B is characterized by a slow onset, with subclinical and chronic types being more common. Acute non-icteric HBsAg-positive patients are prone to chronic disease. The course of chronic hepatitis often exceeds half a year, and the disease can develop insidiously, often discovered during physical examinations. The symptoms vary, with recurrent attacks or prolonged illness. An estimated 5% to 10% of patients with acute hepatitis B develop into chronic hepatitis. The chronicity of acute hepatitis B depends mainly on the age of initial infection, immune status, and viral levels. Infections in infancy and childhood are prone to chronic disease. Patients using immunosuppressants and cytotoxic drugs, and patients with chronic renal failure on hemodialysis often lack obvious acute phase manifestations and have a protracted illness. Patients with very high serum levels of viral replication markers (HBeAg, HBV DNA) are more likely to develop chronic hepatitis.
  • Site of disease:

    liver
  • Infectious :

    Contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Lack of appetite fatigue liver disease appearance liver palm nausea
Related Drugs
Oxymatrine injection
Indication: Used for the treatment of chronic hepatitis B and low white blood cell count caused by tumor radiotherapy and chemotherapy, as well as leukocytopenia caused by other reasons.
Oxymatrine injection
Indication: Used for the treatment of chronic hepatitis B and low white blood cell count caused by tumor radiotherapy and chemotherapy, as well as leukocytopenia caused by other reasons.
Manufacturer:

Dandong Yichuang Pharmaceutical Co., Ltd.

Oxymatrine injection
Indication: Used for the treatment of chronic hepatitis B and low white blood cell count caused by tumor radiotherapy and chemotherapy, as well as leukocytopenia caused by other reasons.
Oxymatrine injection
Indication: Used for the treatment of chronic hepatitis B and low white blood cell count caused by tumor radiotherapy and chemotherapy, as well as leukocytopenia caused by other reasons.
Manufacturer:

Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd.

Oxymatrine injection
Indication: Used for the treatment of chronic hepatitis B and low white blood cell count caused by tumor radiotherapy and chemotherapy, as well as leukocytopenia caused by other reasons.
Manufacturer:

Viwit Pharmaceutical Co., Ltd.

Oxymatrine injection
Indication: Used for the treatment of chronic hepatitis B and low white blood cell count caused by tumor radiotherapy and chemotherapy, as well as leukocytopenia caused by other reasons.
Manufacturer:

Shandong Xinhua Pharmaceutical Company Limited

Oxymatrine injection
Indication: Used for the treatment of chronic hepatitis B and low white blood cell count caused by tumor radiotherapy and chemotherapy, as well as leukocytopenia caused by other reasons.
Oxymatrine injection
Indication: Used for the treatment of chronic hepatitis B and low white blood cell count caused by tumor radiotherapy and chemotherapy, as well as leukocytopenia caused by other reasons.
Manufacturer:

Huarun Shuanghe Limin Pharmaceutical (Ji'nan) Co., Ltd.

Oxymatrine injection
Indication: Used for the treatment of chronic hepatitis B and low white blood cell count caused by tumor radiotherapy and chemotherapy, as well as leukocytopenia caused by other reasons.
Manufacturer:

Zhengzhou Zhuofeng Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.